A detailed history of Chesapeake Asset Management LLC transactions in Organon & Co. stock. As of the latest transaction made, Chesapeake Asset Management LLC holds 30 shares of OGN stock, worth $225. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 30 -0.0%
Holding current value
$225
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Oct 15, 2025

BUY
$8.04 - $14.72 $241 - $441
30 New
30 $0
Q2 2024

Jan 05, 2026

BUY
$17.45 - $21.96 $87 - $109
5 Added 16.67%
35 $724,000
Q1 2024

Jan 05, 2026

SELL
$13.78 - $18.8 $3,720 - $5,076
-270 Reduced 88.52%
35 $658,000
Q3 2023

Jan 05, 2026

SELL
$16.59 - $23.77 $6,636 - $9,508
-400 Reduced 56.74%
305 $5.29 Million
Q2 2023

Jan 05, 2026

SELL
$19.27 - $24.63 $1,541 - $1,970
-80 Reduced 10.19%
705 $14.7 Million
Q1 2023

Jan 05, 2026

BUY
$21.42 - $32.08 $16,172 - $24,220
755 Added 2516.67%
785 $18.5 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Chesapeake Asset Management LLC Portfolio

Follow Chesapeake Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Asset Management LLC with notifications on news.